38 results on '"Komolmit P"'
Search Results
2. 325 COMPARISON EFFICACY AND SAFETY BETWEEN ATEZOLIZUMAB PLUS BEVACIZUMAB AND LENVATINIB AS FIRST-LINE SYSTEMIC THERAPY FOR HEPATOCELLULAR CARCINOMA: A REAL-WORLD STUDY.
3. 252 COMBINATION OF MODIFIED ALBUMIN-BILIRUBIN GRADE AND PLATELET COUNT TO PREDICT VARICES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA.
4. FRI-400 - Involvement of angiotensin II/angiotensin-(1–7) fibrinolytic pathway in improvement of liver fibrosis in chronic hepatitis C patients who had sustained virological response by direct-acting antiviral therapy: a prospective trial
5. Su1569 ASSOCIATION BETWEEN BACTERIAL DNA TRANSLOCATION, SYSTEMIC INFLAMMATION AND HEPATIC ENCEPHALOPATHY IN CIRRHOSIS.
6. Mo1557 SERUM PRESEPSIN, ENDOCAN, PROCALCITONIN, AND BACTERIAL DNA IN THE IDENTIFICATION OF BACTERIAL INFECTION IN PATIENTS WITH CIRRHOSIS: A META-ANALYSIS.
7. Sa1537 DIAGNOSTIC PERFORMANCE OF MAC 2-BINDING PROTEIN GLYCAN ISOMER (M2BPGI) FOR LIVER FIBROSIS ASSESSMENT AND ROLE OF HEPATOCELLULAR CARCINOMA (HCC) PREDICTION; AN UPDATED META-ANALYSIS.
8. Sa1524 PREVALENCE OF HEPATITIS D INFECTION AMONG PATIENTS INFECTED WITH HEPATITIS B AT A TERTIARY CARE CENTER IN THAILAND.
9. THU-134 - Prevalence of Hepatitis E Virus in Solid Organ Transplant Recipients: A Meta-Analysis
10. P0612 : Interferon-gamma-inducible protein 10 promoter polymorphism related with end-of-treatment HBsAg levels and had complementary role in prediction of sustained virologic response to peginterferon in HBeAg-negative chronic hepatitis B: Multicenter study
11. 95: ASSESSMENT AND VALIDATION OF THE TREAT-B SCORE FOR CHRONIC HEPATITIS B VIRUS TREATMENT ELIGIBILITY.
12. P.104 Durability of HBeAg seroconversion following adefovir dipivoxil treatment for chronic hepatitis B (CHB)
13. P.041 Precore, core promoter and X gene mutations of hepatitis B virus in Thai patients with hepatocellular carcinoma: a case-control study
14. Sa1544 - Hepatitis E Seroprevalence and Serum/Feces RNA Positivity in Post Liver Transplant Patients in High-Prevalence Area of Genotype 3: An Interim Result of 8-Month Prospective Follow-Up.
15. Sa1562 - Correlation of Magnetic Resonance Elastography, Fibroscan, Shear Wave Elastography, APRI and FIB-4 for Staging of Liver Fibrosis.
16. Tu1575 - the High Prevalence of Increased Liver Stiffness and Fatty Liver in the Adult Population without Known Liver Disease: A Community-Based Study.
17. Tu1374 Combination Clinical Risk Score and Genetic Vitamin D Receptor Variant (Bsml) Improved Prediction of Colorectal Cancer Risk.
18. Tu1375 Strong Association of Single Nucleotide Polymorphisms of Vitamin D Receptor Gene, BsmI, and Colorectal Cancer in Asian Population.
19. Mo1023 The Single Nucleotide Polymorphism in the Vitamin D Pathway DHCR7 Gene and Pre-Treatment HBV-DNA Strongly Predict HBeAg Loss in HBeAg-Positive Chronic Hepatitis B Patients Treated With Pegylated Interferon: Multicenter Study.
20. 590 Urine Neutrophil Gelatinase-Associated Lipocalin (UNGAL) Level: A Valid Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhotic Patients.
21. Sa1877 Correction of Vitamin D Deficiency in Chronic Hepatitis C Patients Suppressed Serum Fibrotic Markers: A Randomized, Double-Blinded, Placebo-Controlled Study.
22. Su1022 The Association of the CXCL10, Dpp-4 Gene Polymorphisms and Complementary Role for Unfavorable IL-28B Genotype in Prediction of Treatment Response in Asian Patients With Chronic Hepatitis C Virus Infection.
23. Su1003 High Pre-Treatment Serum Interferon-Gamma-Inducible Protein 10 (IP-10) Levels Is Associated With HBsAg Seroconversion After Peginterferon Therapy in HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B.
24. Su1030 Genetic Variation in Vitamin D Pathway DHCR7 Gene Predicts Poor Response to Pegylated Interferon-Alfa Based Therapy in Asian Chronic Hepatitis C Genotype 1-Infected Patients.
25. Updates on early diagnosis and management of hepatocellular carcinoma in HBV
26. Su2063 Comparing Long-Term Outcome of Patients With Wilson's Disease Presenting With Acute Liver Failure Versus Acute-on-Chronic Liver Failure.
27. 539 2-YEAR RESULTS OF TELBIVUDINE (LDT) ROADMAP STUDY VERIFY THE OPTIMAL EFFICACY AND SAFETY RESULTS IN HBEAG POSITIVE CHRONIC HEPATITIS B (CHB) PATIENTS
28. Risk Factors for Breakthrough Infections in Cirrhotics With GI Bleeding Who Already Received Antibiotic Prophylaxis.
29. Predictors for the Mortality of Spontaneous Bacterial Peritonitis(SBP).
30. Efficacy of Prophylactic Intravenous Ciprofloxacin vs. Ceftriaxone for Cirrhotics With Gastrointestinal Hemorrhage: A Randomized Controlled Trial.
31. S1894 Outcomes and Prognostic Factors of Huge (>10 CM) HCC in Patients With and Without Cirrhosis.
32. Favorable Outcome of Orthotopic Liver Transplantation in Very High-Risk Situations
33. P746 VITAMIN D RELATED PATHWAY GENE POLYMORPHISMS ENHANCED THE PREDICTION OF TREATMENT RESPONSE IN ASIAN CHRONIC HEPATITIS C-INFECTED PATIENTS WITH UNFAVORABLE IL-28B rs12979860 GENOTYPES.
34. 1403 ASSOCIATION OF VITAMIN D BINDING PROTEIN GENE POLYMORPHISM rs 222020 AND THERAPEUTIC OUTCOME IN ASIAN PATIENTS WITH CHRONIC HEPATITIS C INFECTION.
35. 360 CXCL10 GENE POLYMORPHISM PREDICTS RAPID VIROLOGIC RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN COMBINATION THERAPY IN ASIAN PATIENTS WITH DIFFICULT-TO-TREAT CHRONIC HEPATITIS C GENOTYPE.
36. 324 EFFECT OF VITAMIN D SUPPLEMENT ON T HELPER1/2 CYTOKINE LEVELS IN CHRONIC HEPATITIS C PATIENTS; A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY.
37. 424 RESPIRATORY ALTERATIONS IN GENOTYPE 2/3 CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON OR ALBINTERFERON-ALFA-2B PLUS RIBAVIRIN IN A RANDOMIZED STUDY
38. 503 Durability of HBeAg seroconversion following adefovir dipivoxil treatment for chronic hepatitis B (CHB)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.